The share of HIV-positive tuberculosis patients on antiretroviral therapy in Malaysia stood at 41.1 units in 2023. Over the last two years, there was an increase of 9.7% from 2021 to 2023. The average annual growth rate (CAGR) in the last five years was 0.14%. Notable fluctuations were seen, with significant peaks in 2015 and 2017.

Future trends to watch for include:

Steady but modest growth in antiretroviral therapy uptake among HIV-positive tuberculosis patients.
Potential for policy changes and healthcare initiatives aimed at improving treatment rates.
Impact of new therapies or public health campaigns on the coverage rates.